Equities Analysts Set Expectations for McKesson Q1 Earnings

McKesson Corporation (NYSE:MCK - Free Report) - Stock analysts at Leerink Partnrs dropped their Q1 2026 EPS estimates for McKesson in a research note issued on Tuesday, July 1st. Leerink Partnrs analyst M. Cherny now forecasts that the company will post earnings of $8.30 per share for the quarter, down from their prior estimate of $8.74. The consensus estimate for McKesson's current full-year earnings is $32.77 per share. Leerink Partnrs also issued estimates for McKesson's Q2 2026 earnings at $8.41 EPS, Q3 2026 earnings at $9.74 EPS and FY2026 earnings at $37.50 EPS.

A number of other equities analysts have also commented on the stock. Mizuho lifted their price target on shares of McKesson from $630.00 to $690.00 and gave the stock a "neutral" rating in a report on Thursday, April 3rd. Wells Fargo & Company set a $766.00 price target on shares of McKesson and gave the stock an "equal weight" rating in a report on Tuesday, June 3rd. Wall Street Zen upgraded shares of McKesson from a "buy" rating to a "strong-buy" rating in a report on Friday, June 27th. Cfra Research lowered shares of McKesson from a "moderate buy" rating to a "hold" rating in a report on Friday, April 4th. Finally, Bank of America lifted their price target on shares of McKesson from $755.00 to $800.00 and gave the stock a "buy" rating in a report on Friday, May 9th. Three research analysts have rated the stock with a hold rating, ten have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $696.42.

McKesson Stock Up 2.0%

Shares of NYSE MCK traded up $13.85 during midday trading on Thursday, reaching $719.30. 392,096 shares of the company were exchanged, compared to its average volume of 924,875. The stock's 50-day moving average price is $713.68 and its 200-day moving average price is $656.07. The stock has a market cap of $89.99 billion, a P/E ratio of 27.85, a PEG ratio of 1.41 and a beta of 0.48. McKesson has a one year low of $464.42 and a one year high of $736.96.

McKesson (NYSE:MCK - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported $10.12 earnings per share for the quarter, topping analysts' consensus estimates of $9.83 by $0.29. The firm had revenue of $90.82 billion for the quarter, compared to analysts' expectations of $94 billion. McKesson had a net margin of 0.92% and a negative return on equity of 201.12%. The company's revenue was up 18.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $6.18 earnings per share.

Institutional Investors Weigh In On McKesson

A number of institutional investors have recently added to or reduced their stakes in the company. T. Rowe Price Investment Management Inc. grew its position in McKesson by 8.5% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 2,847,385 shares of the company's stock worth $1,622,754,000 after purchasing an additional 222,496 shares in the last quarter. Geode Capital Management LLC grew its position in shares of McKesson by 0.4% during the 4th quarter. Geode Capital Management LLC now owns 2,663,303 shares of the company's stock valued at $1,513,195,000 after acquiring an additional 10,015 shares during the period. Franklin Resources Inc. grew its position in shares of McKesson by 4.6% during the 4th quarter. Franklin Resources Inc. now owns 2,620,948 shares of the company's stock valued at $1,493,704,000 after acquiring an additional 114,396 shares during the period. GAMMA Investing LLC grew its position in shares of McKesson by 75,632.7% during the 1st quarter. GAMMA Investing LLC now owns 2,393,152 shares of the company's stock valued at $1,610,567,000 after acquiring an additional 2,389,992 shares during the period. Finally, Norges Bank bought a new position in shares of McKesson during the 4th quarter valued at approximately $1,200,361,000. 85.07% of the stock is owned by institutional investors.

Insider Activity at McKesson

In other McKesson news, CAO Napoleon B. Rutledge, Jr. sold 543 shares of the company's stock in a transaction dated Monday, May 19th. The shares were sold at an average price of $726.51, for a total value of $394,494.93. Following the completion of the sale, the chief accounting officer directly owned 1,972 shares of the company's stock, valued at approximately $1,432,677.72. This represents a 21.59% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Thomas L. Rodgers sold 2,891 shares of the company's stock in a transaction dated Friday, May 30th. The stock was sold at an average price of $712.18, for a total transaction of $2,058,912.38. Following the completion of the sale, the executive vice president directly owned 2,544 shares of the company's stock, valued at $1,811,785.92. The trade was a 53.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 33,117 shares of company stock valued at $23,526,451 over the last quarter. 0.11% of the stock is currently owned by company insiders.

McKesson Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, July 1st. Stockholders of record on Monday, June 2nd were given a dividend of $0.71 per share. This represents a $2.84 annualized dividend and a dividend yield of 0.39%. The ex-dividend date was Monday, June 2nd. McKesson's payout ratio is presently 10.99%.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.